Hamouda Mahmoud, Ebeid Kamal, Darwish Mohamed Elsayed, Shehata Emad Mohammed
Otorhinolaryngology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Phoniatrics Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5420-5427. doi: 10.1007/s12070-024-04996-y. Epub 2024 Sep 11.
Unilateral vocal fold paralysis (UVFP) is a common condition that may have varying economical and personal consequences for those afflicted by it. Patients often have dysphonia as a primary concern and may also experience aspiration in certain cases. This research aimed to assess the voice and swallowing results after injection laryngoplasty and medialization thyroplasty in patients with UVFP.
This prospective study was carried out on 20 consecutive patients suffering from moderate to severe dysphonia with or without aspiration, with ages ranging from 22 to 61 years old, with clinical criteria of UVFP with glottic gap approximately ≥ 2 mm not responding to voice therapy at least 6 months after the onset of paralysis.
All patient showed improvement in their symptoms evaluated by objective (acoustic and aerodynamic), subjective (GRBAS scale and VHI 10) voice assessment and swallowing parameters. MT showed significant improvement when compared to injection laryngoplasty (IL) at 3 months post-operative in contrast to nearly similar outcome at 2 weeks post-operative.
Significant short-term improvements in dysphonia and aspiration were obtained with medialization thyroplasty and injection laryngoplasty. Patients with mild to moderate gaps who complained of dysphonia alone preferred to start with injection, while patients with moderate to large gaps who complained of dysphonia + aspiration preferred MT (±)AA. Even at short time evaluation, medialization thyroplasty is superior to IL for patients with aspiration.
单侧声带麻痹(UVFP)是一种常见病症,对患者可能产生不同程度的经济和个人影响。患者通常主要关注发声困难,某些情况下还可能出现误吸。本研究旨在评估注射喉成形术和甲状软骨内移术治疗单侧声带麻痹患者后的嗓音和吞咽结果。
本前瞻性研究对20例连续的患者进行,这些患者年龄在22至61岁之间,患有中度至重度发声困难,伴有或不伴有误吸,符合单侧声带麻痹的临床标准,声门间隙约≥2mm,在麻痹发作后至少6个月对嗓音治疗无反应。
通过客观(声学和空气动力学)、主观(GRBAS量表和VHI 10)嗓音评估以及吞咽参数评估,所有患者的症状均有改善。与注射喉成形术(IL)相比,甲状软骨内移术(MT)在术后3个月时显示出显著改善,而术后2周时结果几乎相似。
甲状软骨内移术和注射喉成形术在短期内可显著改善发声困难和误吸。仅抱怨发声困难的轻度至中度声门间隙患者更倾向于先进行注射治疗,而抱怨发声困难 + 误吸的中度至大声门间隙患者更倾向于甲状软骨内移术(±)杓状软骨内移术(AA)。即使在短期评估中,对于有误吸的患者,甲状软骨内移术也优于注射喉成形术。